Market Overview

Piper Jaffray Expands Healthcare Equity Research with Addition of Danielle Brill and Joe Catanzaro

Share:

Piper
Jaffray Companies
(NYSE:PJC), a leading investment bank and asset
management firm, is pleased to announce the hiring of Danielle Brill and
Joe Catanzaro as senior research analysts in its healthcare equity
research group. Covering the biotech sector, Brill and Catanzaro will be
based in the firm's New York office.

"Biopharma is core to our strategy at Piper Jaffray and these hires
demonstrate our commitment to providing our institutional and corporate
clients with the highest-quality equity research in the industry," said Michael
Cox
, co-head of global equities at Piper Jaffray. "When combined
with recent additions in sales and trading, we now have one of the
broadest biopharma equities platforms on Wall Street."

Brill has more than 10 years' experience in the pharmaceutical industry.
Prior to joining Piper Jaffray, Brill was an analyst with Needham &
Company covering smid-cap biotech companies. Brill also worked as a
clinical pharmacist at Mount Sinai Hospital and Premier Inc., and as a
senior research technician at New York University and Columbia
University Medical Center. She received a bachelor's degree in biology
from Michigan State University and earned a doctorate of pharmacy from
Ernest Mario School of Pharmacy at Rutgers University.

Prior to joining Piper Jaffray, Catanzaro was a biotech equity research
associate at Cowen Inc., where he led the production of Cowen's biannual Investor's
Guide to Immuno-Oncology
. Prior to Cowen Inc., Catanzaro served as a
graduate research assistant at Stony Brook University School of Medicine
and authored several publications in peer-reviewed journals. Catanzaro
received a bachelor's degree in biology from Binghamton University and
earned a doctorate in genetics from Stony Brook University School of
Medicine.

Piper Jaffray Companies (NYSE:PJC) is a leading investment bank and
asset management firm. Securities brokerage and investment banking
services are offered in the U.S. through Piper Jaffray & Co., member
SIPC and FINRA; in Europe through Piper Jaffray Ltd., authorized and
regulated by the U.K. Financial Conduct Authority; and in Hong Kong
through Piper Jaffray Hong Kong Limited, authorized and regulated by the
Securities and Futures Commission. Asset management products and
services are offered through five separate investment advisory
affiliates―U.S. Securities and Exchange Commission (SEC) registered
Advisory Research, Inc., Piper Jaffray Investment Management LLC, PJC
Capital Partners LLC and Piper Jaffray & Co., and Guernsey-based
Parallel General Partners Limited, authorized and regulated by the
Guernsey Financial Services Commission.

Follow Piper Jaffray: LinkedIn
| Facebook
| Twitter

© 2018 Piper Jaffray Companies. 800 Nicollet Mall, Suite 1000,
Minneapolis, Minnesota 55402-7036

View Comments and Join the Discussion!